TMA Scorer
Looking to enter your results for a CPQA-AQCP survey? Head over to TMA Scorer.
| September 2022 | Run 180 CD117 Run 181 CD20 Run 182 Breast HER2 ISH Run 183 H&E |
| October 2022 | Run 184 ALK IHC |
| November 2022 | Run 185 ki67 Run 186 Breast module (ER/PR/HER2) Run 187 1p19q FISH |
| December 2022 | Run 188 ATRX & IDH1 Run 189 p53 (vulvar) |
| January 2023 | Run 191 p63/AMACR/prostate basal epithelial cytokeratin Run 192 gHER2 ISH Run 194 gHER2 IHC Run 194 HMB45 |
| February 2023 | Run 195 Breast HER2 IHC with emphasis on HER2-low (free participation courtesy of AstraZeneca) Run 196 PD-L1 (technical assessment only) Run 197 MMR |
| March 2023 | Run 198 H&E Run 199 HSV Run 200 ER & PR Breast |
| April 2023 | Run 201 c-Myc (lymphomas) Run 202 pan-TRK IHC |
| May 2023 | Run 203 Breast HER2 IHC with emphasis on HER2-low (free participation courtesy of AstraZeneca) Run 204 BRAFV600E Run 205 ROS1 (technical assessment) |
| June 2023 | Run 206 p53 endometrial Run 207 Chromogranin A Run 208 gHER2 IHC |
| July 2023 | Run 209 p16 Run 210 CK20 Run 211 CD117 |
| August 2023 | Run 212 ALK ISH Run 213 PD-L1 (technical assessment) Run 214 HER2 ISH |
| September 2023 | Run 215 Breast HER2 IHC with emphasis on HER2-low (free participation courtesy of AstraZeneca) Run 216 CD20 Run 217 H&E Run 218 Synaptophysin Run 219 ALK IHC |
| October 2023 | Run 220 ER & PR Breast Run 221 KI67 Run M3 CRC Molecular Survey (Postponed until 2024) |
| November 2023 | Run 222 Calretinin Run 223 IDH1 & ATRX Run 224 1p19q FISH |
| December 2023 | Run 225 Breast HER2 IHC with emphasis on HER2-low (free participation courtesy of AstraZeneca) Run 226 p53 vulvar |
